My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Nicorette Invisi 15mg/16 hours Transdermal Patch



Lexon Pharmaceuticals (Ireland) LimitedPPA23176/051/001

Main Information

Trade NameNicorette Invisi 15mg/16 hours Transdermal Patch
Active SubstancesNicotine
Dosage FormTransdermal patch
Licence HolderLexon Pharmaceuticals (Ireland) Limited
Licence NumberPPA23176/051/001

Group Information

ATC CodeN07BA Drugs used in nicotine dependence
N07BA01 nicotine

Status

License statusAuthorised
Licence Issued30/09/2022
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through non-pharmacy outlets and pharmacies
Advertising StatusAdvertising to the general public
Conditions of LicenceIn general sale outlets can only be sold or supplied to adults aged 18 years or above. Product not subject to medical prescription for a maximum daily dose of 22 mg expressed as the dose delivered over a 24-hour period.
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back
Follow medicine

Print